Avacta Group Future Growth
Future criteria checks 1/6
Avacta Group's earnings are forecast to decline at 0.5% per annum while its annual revenue is expected to grow at 9% per year. EPS is expected to grow by 9.3% per annum. Return on equity is forecast to be -63% in 3 years.
Key information
-0.5%
Earnings growth rate
9.3%
EPS growth rate
| Biotechs earnings growth | 25.3% |
| Revenue growth rate | 9.0% |
| Future return on equity | -63.0% |
| Analyst coverage | Low |
| Last updated | 06 May 2024 |
Recent future growth updates
Recent updates
Investors Give Avacta Group Plc (LON:AVCT) Shares A 26% Hiding
Feb 23
Getting In Cheap On Avacta Group Plc (LON:AVCT) Is Unlikely
Aug 05Would Avacta Group (LON:AVCT) Be Better Off With Less Debt?
Jun 22We're Hopeful That Avacta Group (LON:AVCT) Will Use Its Cash Wisely
Oct 20This Is The Reason Why We Think Avacta Group Plc's (LON:AVCT) CEO Deserves A Bump Up To Their Compensation
Jun 22Avacta Group (LON:AVCT) Is In A Good Position To Deliver On Growth Plans
Jun 20Avacta Group Plc (LON:AVCT) Insiders Have Been Selling
Feb 18Companies Like Avacta Group (LON:AVCT) Are In A Position To Invest In Growth
Jan 23
What Kind Of Shareholders Hold The Majority In Avacta Group Plc's (LON:AVCT) Shares?
Dec 27How Is Avacta Group's (LON:AVCT) CEO Paid Relative To Peers?
Dec 06Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2026 | 30 | -25 | -27 | -29 | 2 |
| 12/31/2025 | 29 | -27 | -27 | -28 | 3 |
| 12/31/2024 | 25 | -27 | -27 | -28 | 2 |
| 12/31/2023 | 23 | -25 | -16 | -15 | N/A |
| 9/30/2023 | 20 | -34 | -14 | -13 | N/A |
| 6/30/2023 | 16 | -42 | -16 | -15 | N/A |
| 3/31/2023 | 13 | -41 | -16 | -16 | N/A |
| 12/31/2022 | 10 | -40 | -17 | -16 | N/A |
| 9/30/2022 | 8 | -32 | -21 | -20 | N/A |
| 6/30/2022 | 7 | -25 | -21 | -20 | N/A |
| 3/31/2022 | 5 | -26 | -21 | -20 | N/A |
| 12/31/2021 | 3 | -26 | -22 | -21 | N/A |
| 6/30/2021 | 2 | -20 | -18 | -16 | N/A |
| 3/31/2021 | 2 | -18 | -15 | -14 | N/A |
| 12/31/2020 | 2 | -16 | -12 | -11 | N/A |
| 6/30/2020 | 5 | -12 | -9 | -8 | N/A |
| 3/31/2020 | 4 | -12 | -10 | -9 | N/A |
| 12/31/2019 | 4 | -11 | -11 | -9 | N/A |
| 7/31/2019 | 4 | -10 | -10 | -8 | N/A |
| 4/30/2019 | 3 | -10 | -9 | -6 | N/A |
| 1/31/2019 | 2 | -10 | -7 | -5 | N/A |
| 10/31/2018 | 3 | -9 | -8 | -5 | N/A |
| 7/31/2018 | 3 | -9 | -8 | -5 | N/A |
| 4/30/2018 | 3 | -8 | -8 | -6 | N/A |
| 1/31/2018 | 3 | -7 | -8 | -6 | N/A |
| 10/31/2017 | 3 | -7 | N/A | -5 | N/A |
| 7/31/2017 | 3 | -6 | N/A | -4 | N/A |
| 4/30/2017 | 3 | -6 | N/A | -4 | N/A |
| 1/31/2017 | 2 | -6 | N/A | -5 | N/A |
| 10/31/2016 | 2 | -5 | N/A | -4 | N/A |
| 7/31/2016 | 2 | -5 | N/A | -4 | N/A |
| 4/30/2016 | 2 | -5 | N/A | -3 | N/A |
| 1/31/2016 | 2 | -5 | N/A | -3 | N/A |
| 10/31/2015 | 2 | -5 | N/A | -3 | N/A |
| 7/31/2015 | 2 | -5 | N/A | -3 | N/A |
| 4/30/2015 | 2 | -4 | N/A | -2 | N/A |
| 1/31/2015 | 2 | -3 | N/A | -2 | N/A |
| 10/31/2014 | 2 | -2 | N/A | -1 | N/A |
| 7/31/2014 | 2 | -1 | N/A | -1 | N/A |
| 4/30/2014 | 2 | -1 | N/A | -1 | N/A |
| 1/31/2014 | 2 | -1 | N/A | -1 | N/A |
| 10/31/2013 | 3 | -1 | N/A | -1 | N/A |
| 7/31/2013 | 3 | -2 | N/A | -1 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: AVCT is forecast to remain unprofitable over the next 3 years.
Earnings vs Market: AVCT is forecast to remain unprofitable over the next 3 years.
High Growth Earnings: AVCT is forecast to remain unprofitable over the next 3 years.
Revenue vs Market: AVCT's revenue (9% per year) is forecast to grow faster than the UK market (3.5% per year).
High Growth Revenue: AVCT's revenue (9% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: AVCT is forecast to be unprofitable in 3 years.